Sputnik V second dose deficiency to defer India’s full rollout: Dr Reddy’s Kumar Jeetendra | July 12, 2021 India’s full rollout of the Sputnik V COVID-19 vaccine will have to be put on hold until the Russian producer provides equal quantities of its two differing doses, Dr. Reddy’s Laboratories Ltd said on Monday. Dr. Reddy’s had received about 3 million first doses by June 1 and about 360,000 doses of the second by …
Blood thinner may lessen death risk in decently sick COVID-19 patients: Study Kumar Jeetendra | July 14, 2021 Administering a full dose of a standard blood thinner early to moderately ill hospitalised patients with COVID-19 could halt the formation of blood clots and reduce the risk of severe disease and death, according to a study. COVID-19 is marked by heightened inflammation and abnormal clotting in the blood vessels, particularly in the lungs, and …
Analysts study the role of subnuclear NSrp70 in T cell-intervened adaptive immunity Kumar Jeetendra | July 15, 2021 T cell are part of the body’s immune response. The way proteins are spliced in their development and maturation determines how T cells can recognize different pathogens and mount defense against them. Scientists from Korea now highlight the role of NSrp70 in regulating maturation. This protein was previously found in T cells subnuclear space and …
Over 40.31 crore COVID-19 immunization dosages so far gave to states/UTs: Center Kumar Jeetendra | July 15, 2021 Over 40.31 crore COVID-19 vaccine doses have so far been provided to states/UTs in the country and more than 1.92 crore balance and unutilised jabs are still available with them and private hospitals, the health ministry said on Thursday. In a statement, the ministry said 83,85,790 more doses are in the pipeline. “More than 40.31 …
HIV ‘significant’ risk factor for severe COVID: WHO Kumar Jeetendra | July 15, 2021 HIV is a “significant” risk factor for severe COVID-19, the World Health Organization said in research published on Thursday that showed a major increase in deaths among patients who have the virus that causes AIDS and are also hospitalised with COVID-19. There are more than 37 million people known to be living with HIV globally, …
China must co-work better with COVID origin test: WHO Kumar Jeetendra | July 15, 2021 China must co-operate better in the probe into the origins of the coronavirus pandemic, the first cases of which were seen in Wuhan in December 2019, the head of World Health Organization said on Thursday. “We hope there will be better co-operation to get to the bottom of what happened,” Tedros Adhanom Ghebreyesus told a …
IISc-Bengaluru’s ‘warm’ COVID vaccine powerful against all significant variants of concern: Study Kumar Jeetendra | July 16, 2021 A heat-tolerant COVID-19 vaccine formulation developed by the Indian Institute of Science (IISc) Bengaluru has proven effective against all current SARS-CoV-2 variants of concern, according to a study in animals. The research, published in the ACS Infectious Diseases journal on Thursday, showed the vaccine formulations by IISc-incubated biotech start-up Mynvax triggered a strong immune response …
Bharat Biotech’s partner Ocugen looks for endorsement for Covaxin in Canada Kumar Jeetendra | July 16, 2021 Ocugen Inc., Bharat Biotech’s partner for USA and Canada for COVID-19 vaccine Covaxin has initiated a rolling submission to Health Canada for the jab, the US company said in a regulatory filing. The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly 25,800 adults, …
UK plans biggest flu program with free immunizations for millions Kumar Jeetendra | July 17, 2021 UK’s Health and Social Care Secretary Sajid Javid on Saturday announced that millions of more people will be offered a free flu vaccine this year as part of the British government’s most comprehensive flu vaccination programme in history to help back up the coronavirus fight. From September, the National Health Service (NHS) will offer the …
Central amygdala micro circuits assume dynamic part in regulation of dread responses Kumar Jeetendra | July 17, 2021 Because they can be used to treat anxiety disorders, the brain mechanisms that suppress fear reactions have been a focus of much attention. Although we have a good understanding of the brain regions that are activated when fear is experienced, it remains to be largely unknown how fear reactions can be suppressed. Researchers from the …
Top 10 CROs of India to look upon 2022 Kumar Jeetendra | July 17, 2021 Nominations for “Top 10 CROs of India to look upon 2022” are open from 23 November 2021 and will close on 15 January 2022 Click here to Nominate your Organization In Association with & Important Note: 1.Nominations for “Top 10 CROs of India to look upon 2022” are open from 23 November 2021 and will close …
IISc-incubated vaccine innovation startup Mynvax raises $4.2 million Kumar Jeetendra | July 19, 2021 Mynvax, a vaccine technology startup incubated by the Society for Innovation and Development (SID) at the Indian Institute of Science, on Monday announced that it has signed definitive agreements to raise $4.2 million (Rs 31 crore) in its Series A round of financing led by Accel. The company said in a statement it is developing …
